Take One: Big story of the day
-
HCQ to Ivermectin: Why India has got it wrong in Covid-19 treatment
There are drugs that continue to be on the health ministry's treatment protocol despite evidence not inspiring confidence, while the regulator is approving medicines without following due scientific process, experts say
-
Get, Set, Go: Why Ather Energy is ready to ride the hockey-stick growth
With a new factory, launch of its premium scooter 450X and expansion into several cities, the electric vehicle company is set to move into serious production mode. Positive unit economics have kicked in too, says its co-founders
-
Facebook, WhatsApp sue Indian government over traceability requirement
In two separate petitions filed in the Delhi High Court, Facebook and WhatsApp have challenged the traceability requirement in the Intermediary Rules, and asked the court not to impose criminal liability if traceability is not implemented. Forbes India, after reviewing the petitions, summarises the arguments made
-
IDBI Bank: Time to revisit its vision
IDBI Bank has exited the PCA framework with its brand value intact. But it needs to restart its growth engine to succeed as a turnaround bank, and make money for primary investor LIC
-
After pursuing terrorists, Delhi Police Special Cell investigates Twitter's 'manipulated media' policy
In the middle of a lockdown, Delhi Police's Special Cell turns up at the offices of social media platform Twitter in Delhi NCR to get "satisfactory" answers on its tweet labelling policy
-
Can wildfires be prevented in a world dealing with climate change?
India recorded 82,170 forest fire alerts from April 1 to 14, nearly doubling from 43,031 in the same period in 2020. Forest fires, wildfires and their alerts in the country have gone up sharply in recent times, posing a serious threat to our environment, wildlife and biodiversity
-
The World and the vaxed (and the vexed): Part II
In the final part of our vaccine story that delves into the experiences of global citizens who have taken the jab and those waiting for their turn, we speak to respondents in China, Germany, Singapore, Sint Maarten (Netherlands Antilles), Switzerland, Australia, UAE, South Africa, United Kingdom and Belgium
-
Will Wendy's get a bigger bite of the Indian market this time?
In a global first, Wendy's cloud kitchen tie-up with Rebel Foods gives it a chance to come back in the game in India. Can the world's third biggest burger brand flip the bun?
-
The World and the vaxed (and the vexed)
As India lays out an ambitious vaccine programme till the year-end, Forbes India delves into the experiences of global citizens who have taken the jab and of those waiting for their turn
-
Mister India: Inside Xiaomi's transformation into a Made-in-India brand
Manu Jain has pulled out all stops to project the born-in-China Xiaomi as a made in India label, but is there a flipside to building the brand around an individual?
-
India finally has a third vaccine. Is it enough to save the country?
The contentious Sputnik V vaccine, of which close to 900 million doses are being manufactured in India, is being administered at time when the pace of inoculations is alarmingly behind schedule